Stem Cell Therapy for Osteonecrosis of Femoral Head: Opportunities and Challenges

Overview

Journal Regen Ther

Date 2021 Jan 11

PMID 33426232

Citations 37

Authors

Yingxing Xu

Yaping Jiang

ChangSuo Xia

Yingzhen Wang

Zhiping Zhao

Tao Li

Affiliations

Soon will be listed here.

Abstract

Osteonecrosis of the femoral head (ONFH) is a progressive disease with a complex etiology and unclear pathogenesis, resulting in severe hip pain and dysfunction mainly observed in young patients. Although total hip arthroplasty (THA) is the most effective treatment for patients with ONFH in the terminal stage, the results of THA in young patients or active populations are often not favorable, with some complications related to the prosthesis. With the development of biotechnology, an increasing number of studies pay attention to use of stem cells for the treatment of ONFH. Stem cells are characterized by the ability to self-renew and differentiate into multiple cell types, including differentiation into osteoblasts and endothelial cells to mediate bone repair and angiogenesis. Furthermore, stem cells can offer growth factors to promote blood supply in the necrotic regions by paracrine effects. Therefore, stem cell therapy has become one of the hip-preserving alternatives for ONFH. This review summarized the current trends in stem cell therapy for ONFH, from clinical applications to related basic research, and showed that an increasing number of studies have confirmed the effectiveness of stem cell therapy in ONFH. However, many unsolved problems and challenges in practical applications of stem cell therapy still exist, such as patient selection, standardized procedures, safety assessment, and the fate of transplanted cells in the body. Additional studies are required to find ideal cell sources, appropriate transplantation methods, and the optimal number of cells for transplantation.

Citing Articles

Polydopamine grafting polyether ether ketone to stabilize growth factor for efficient osteonecrosis repair.

Sun Y, Liu J, Chen K, Zhong N, He C, Luan X Sci Rep. 2025; 15(1):3697.

PMID: 39880837 PMC: 11779900. DOI: 10.1038/s41598-025-86965-1.

Therapeutic effect of low-dose BMSCs-Loaded 3D microscaffold on early osteonecrosis of the femoral head.

Guo M, Qi B, Pei Z, Ni H, Ren J, Luo H Mater Today Bio. 2025; 30():101426.

PMID: 39850243 PMC: 11755031. DOI: 10.1016/j.mtbio.2024.101426.

Bioinformatics and Gene Expression Omnibus Analysis of Key Candidate Genes and Pathways Associated with Femoral Head Necrosis.

Ding Y, Ma Y, Yan H, Zhang E Iran J Pharm Res. 2025; 23(1):e145223.

PMID: 39830663 PMC: 11742569. DOI: 10.5812/ijpr-145223.

Angiogenesis of Avascular Necrosis of the Femoral Head: A Classic Treatment Strategy.

Wang P, Shao W, Wang Y, Wang B, Lv X, Feng Y Biomedicines. 2024; 12(11).

PMID: 39595143 PMC: 11591661. DOI: 10.3390/biomedicines12112577.

Pathological mechanisms and related markers of steroid-induced osteonecrosis of the femoral head.

Li L, Zhao S, Leng Z, Chen S, Shi Y, Shi L Ann Med. 2024; 56(1):2416070.

PMID: 39529511 PMC: 11559024. DOI: 10.1080/07853890.2024.2416070.

References

Fu Q, Tang N, Zhang Q, Liu Y, Peng J, Fang N . Preclinical Study of Cell Therapy for Osteonecrosis of the Femoral Head with Allogenic Peripheral Blood-Derived Mesenchymal Stem Cells. Yonsei Med J. 2016; 57(4):1006-15. PMC: 4951443. DOI: 10.3349/ymj.2016.57.4.1006. View

Afizah H, Hui J . Mesenchymal stem cell therapy for osteoarthritis. J Clin Orthop Trauma. 2016; 7(3):177-82. PMC: 4949411. DOI: 10.1016/j.jcot.2016.06.006. View

Mostafavi Tabatabaee R, Saberi S, Parvizi J, Mortazavi S, Farzan M . Combining Concentrated Autologous Bone Marrow Stem Cells Injection With Core Decompression Improves Outcome for Patients with Early-Stage Osteonecrosis of the Femoral Head: A Comparative Study. J Arthroplasty. 2015; 30(9 Suppl):11-5. DOI: 10.1016/j.arth.2015.06.022. View

Fang S, Li Y, Chen P . Osteogenic effect of bone marrow mesenchymal stem cell-derived exosomes on steroid-induced osteonecrosis of the femoral head. Drug Des Devel Ther. 2018; 13:45-55. PMC: 6305133. DOI: 10.2147/DDDT.S178698. View

Santelli J, Lechevallier S, Baaziz H, Vincent M, Martinez C, Mauricot R . Multimodal gadolinium oxysulfide nanoparticles: a versatile contrast agent for mesenchymal stem cell labeling. Nanoscale. 2018; 10(35):16775-16786. DOI: 10.1039/c8nr03263g. View

Spees J, Lee R, Gregory C . Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther. 2016; 7(1):125. PMC: 5007684. DOI: 10.1186/s13287-016-0363-7. View

Swarup I, Shields M, Mayer E, Hendow C, Burket J, Figgie M . Outcomes after total hip arthroplasty in young patients with osteonecrosis of the hip. Hip Int. 2017; 27(3):286-292. DOI: 10.5301/hipint.5000457. View

Kinnaird T, Stabile E, Burnett M, Lee C, Barr S, Fuchs S . Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004; 94(5):678-85. DOI: 10.1161/01.RES.0000118601.37875.AC. View

Moya-Angeler J, Gianakos A, Villa J, Ni A, Lane J . Current concepts on osteonecrosis of the femoral head. World J Orthop. 2015; 6(8):590-601. PMC: 4573503. DOI: 10.5312/wjo.v6.i8.590. View

10.

Kang P, Xie X, Tan Z, Yang J, Shen B, Zhou Z . Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs. J Mater Sci Mater Med. 2015; 26(2):80. DOI: 10.1007/s10856-015-5402-x. View

11.

Feng Y, Yang S, Xiao B, Xu W, Ye S, Xia T . Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone. 2009; 46(1):32-40. DOI: 10.1016/j.bone.2009.09.001. View

12.

Guo S, Tao S, Yin W, Qi X, Sheng J, Zhang C . Exosomes from Human Synovial-Derived Mesenchymal Stem Cells Prevent Glucocorticoid-Induced Osteonecrosis of the Femoral Head in the Rat. Int J Biol Sci. 2016; 12(10):1262-1272. PMC: 5069447. DOI: 10.7150/ijbs.16150. View

13.

Peng J, Wen C, Wang A, Wang Y, Xu W, Zhao B . Micro-CT-based bone ceramic scaffolding and its performance after seeding with mesenchymal stem cells for repair of load-bearing bone defect in canine femoral head. J Biomed Mater Res B Appl Biomater. 2011; 96(2):316-25. DOI: 10.1002/jbm.b.31770. View

14.

Ma X, Cui D, Zhao D . Vascular endothelial growth factor/bone morphogenetic protein-2 bone marrow combined modification of the mesenchymal stem cells to repair the avascular necrosis of the femoral head. Int J Clin Exp Med. 2015; 8(9):15528-34. PMC: 4658933. View

15.

Hartley W, McAuley J, Culpepper W, Engh Jr C, Engh Sr C . Osteonecrosis of the femoral head treated with cementless total hip arthroplasty. J Bone Joint Surg Am. 2000; 82(10):1408-13. DOI: 10.2106/00004623-200010000-00006. View

16.

Hernigou P, Beaujean F . Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002; (405):14-23. DOI: 10.1097/00003086-200212000-00003. View

17.

Li Z, Hu H, Zhang X, Liu G, Ran B, Zhang P . MiR-291a-3p regulates the BMSCs differentiation via targeting DKK1 in dexamethasone-induced osteoporosis. Kaohsiung J Med Sci. 2019; 36(1):35-42. DOI: 10.1002/kjm2.12134. View

18.

Pepke W, Kasten P, Beckmann N, Janicki P, Egermann M . Core Decompression and Autologous Bone Marrow Concentrate for Treatment of Femoral Head Osteonecrosis: A Randomized Prospective Study. Orthop Rev (Pavia). 2016; 8(1):6162. PMC: 4821226. DOI: 10.4081/or.2016.6162. View

19.

Lee H, Huang G, Chiang H, Chiou L, Chen M, Hsieh C . Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells. 2003; 21(2):190-9. DOI: 10.1634/stemcells.21-2-190. View

20.

Song H, Lan B, Cheng B, Zhang K, Yan H, Wang W . Peripheral blood stem cell transplantation for ischemic femoral head necrosis. Transplant Proc. 2010; 42(5):1862-4. DOI: 10.1016/j.transproceed.2010.02.077. View